Revefenacin: Difference between revisions
Jump to navigation
Jump to search
| Line 26: | Line 26: | ||
==IV Compatibility== | ==IV Compatibility== | ||
*Intravenous solution in healthy volunteers | |||
**Volume of distribution was 218 L | |||
**Intravenous solution radioactivity: | |||
**54% came out as solid waste | |||
**27% came out as liquid waste | |||
==Pharmacology== | ==Pharmacology== | ||
Revision as of 03:38, 8 October 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Uma Maveli[2]
Overview
Adult Indications and Dosage
- The agreed dosage is 175 micrograms per day
- Taken via a standard jet nebulizer (turns liquid medication into mist) connected to an air compressor
- Makes it easy for patients with pulmonary problems
Pediatric Indications and Dosage
Contradictions
Warnings
Adverse Reactions
Side Effects
- Headache
- Cough
- Problems regarding the upper respiratory system
- Back Pain
Drug Interactions
Use in Specific Populations
IV Compatibility
- Intravenous solution in healthy volunteers
- Volume of distribution was 218 L
- Intravenous solution radioactivity:
- 54% came out as solid waste
- 27% came out as liquid waste
Pharmacology
Clinical Studies
How is it supplied
Patient Counseling Information
Precautions with Alcohol
Brand Names
- Yupelri